Zydus Lifesciences Ltd. with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

With this latest approval, Zydus now holds 418 approvals from the USFDA. The company has filed 483 Abbreviated New Drug Applications (ANDAs), since it began the filing process in fiscal year 2003 ...

The shares of Zydus Lifesciences Limited were trading at ₹877.90 up by ₹6.25 or 0.72 per cent on the NSE today at 10.25 am. The company has dramatically reduced the cost of CMV prophylaxis by ...

Zydus, a global lifesciences company specialising in novel, affordable and highly impactful vaccines will collaborate with a partner for the research and co-development of a combination vaccine ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough ... ANVIMO will be available in dosages of 240 mg and 480 mg. According to the company’s statement, CMV infection remains ...

Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.

In the year 2003, German Remedies, Recon Healthcare, Zoom Properties and Zydus Pathline merged with the company. Also, they acquired Alpharma France, which spearheaded the group operations in France.